ABC, GCB, and Double-Hit Diffuse Large B-Cell Lymphoma: Does Subtype Make a Difference in Therapy Selection?

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting

Volumn , Issue , 2015, Pages e449-e457

  Nowakowski, Grzegorz S ^a   Czuczman, Myron S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

GENE EXPRESSION PROFILING; GENETICS; HUMAN; LYMPHOMA, LARGE B-CELL, DIFFUSE; PATHOLOGY; PERSONALIZED MEDICINE; PROCEDURES;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; GENE EXPRESSION PROFILING; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; PRECISION MEDICINE;

EID: 84965189694     PISSN: None     EISSN: 15488756     Source Type: Journal    
DOI: 10.14694/EdBook_AM.2015.35.e449     Document Type: Review

References (0)